Cavidi is the company behind Exazym®, which solves a critical research challenge: ultra-sensitive detection of low-abundance biomarkers using standard immunoassay workflows. It enables biomarker detection by amplifying immunoassay signals up to 100x with minimal background noise, allowing researche...